| Literature DB >> 30100074 |
Tracy-Ann Moo1, Rachel Sanford2, Chau Dang2, Monica Morrow3.
Abstract
Breast cancer treatment is multidisciplinary. Most women with early stage breast cancer are candidates for breast-conserving surgery with radiotherapy or mastectomy. The risk of local recurrence and the chance of survival does not differ with these approaches. Sentinel node biopsy is used for axillary staging, and individualized approaches are minimizing the need for axillary dissection in women with positive sentinel nodes. Adjuvant systemic therapy is used in most women based on proven survival benefit, and molecular profiling to individualize treatment based on risk is now a clinical reality for patients with hormone receptor-positive cancers.Entities:
Keywords: Adjuvant therapy; Breast cancer surveillance; Breast cancer therapy; Breast-conserving therapy; Endocrine therapy; Local therapy; Mastectomy; Neoadjuvant chemotherapy
Mesh:
Year: 2018 PMID: 30100074 PMCID: PMC6092031 DOI: 10.1016/j.cpet.2018.02.006
Source DB: PubMed Journal: PET Clin ISSN: 1556-8598